33
Participants
Start Date
November 22, 2023
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Chidamide combined with Linperlisib
Specified dose on specified days: Cedarbenzamide (C) 20mg orally twice weekly, Limplica (L) 80mg once daily, 2 weeks on 2 weeks off, Repeat on day 28.
RECRUITING
Bing Xu, Xiamen
Fujian Provincial Hospital
OTHER
Fujian Cancer Hospital
OTHER_GOV
Zhangzhou Affiliated Hospital of Fujian Medical University
OTHER
Jieyang People's Hospital
OTHER
Dongguan People's Hospital
OTHER_GOV
Huizhou Municipal Central Hospital
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
Sun Yat-sen University
OTHER
Shanxi Province Cancer Hospital
OTHER
The First Affiliated Hospital of Xiamen University
OTHER